Page 6 - American Thoracic Society

Medications

IPF drug fails in new trial

A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis (IPF).

Sleep disorders

Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Diseases, Conditions, Syndromes

Cell division abnormality contributes to inflammation in COPD

Changes in the ability of lung cells to divide may play a role in initiating or prolonging lung tissue inflammation, a hallmark of chronic obstructive pulmonary disease (COPD), according to a study conducted by researchers ...

Medical research

Research links telomere length to emphysema risk

Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University.

Health

Extreme heat associated with children's asthma hospital visits

For children seeking care at a California urban pediatric health center, extreme heat events were associated with increased asthma hospital visits, according to research published at the ATS 2024 International Conference ...

page 6 from 40